As of 30 Sep 2025, 3 institutional investors reported holding 112,107 shares of Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB). This represents 0.88% of the company’s total 12,703,253 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 112,107 | $190,731 | +$190,731 | $1.70 | 3 |